Related references
Note: Only part of the references are listed.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Angelo Ravelli et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Angelo Ravelli et al.
RMD OPEN (2016)
Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
Shumpei Yokota et al.
JOURNAL OF RHEUMATOLOGY (2015)
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
Mikhail M. Kostik et al.
PEDIATRIC RHEUMATOLOGY (2015)
Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
V. Boom et al.
PEDIATRIC RHEUMATOLOGY (2015)
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
Mikhail M. Kostik et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period
Kenan Barut et al.
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS (2015)
Reviewing the Recommendations for Lupus in Children
Zehra Serap Arici et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature
Guido Granata et al.
CASE REPORTS IN MEDICINE (2015)
Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
Shumpei Yokota et al.
JOURNAL OF RHEUMATOLOGY (2014)
Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis
Colleen K. Correll et al.
PEDIATRIC RESEARCH (2014)
Genetic Defects in Cytolysis in Macrophage Activation Syndrome
Mingce Zhang et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A Multinational, Multicenter Study of 362 Patients
Francesca Minoia et al.
ARTHRITIS & RHEUMATOLOGY (2014)
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Sarah Ringold et al.
ARTHRITIS AND RHEUMATISM (2013)
Interferon-γ Mediates Anemia but Is Dispensable for Fulminant Toll-like Receptor 9-Induced Macrophage Activation Syndrome and Hemophagocytosis in Mice
Scott W. Canna et al.
ARTHRITIS AND RHEUMATISM (2013)
Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review
Soamarat Vilaiyuk et al.
CLINICAL RHEUMATOLOGY (2013)
Monocyte-Derived Dendritic Cells Perform Hemophagocytosis to Fine-Tune Excessive Immune Responses
Hideaki Ohyagi et al.
IMMUNITY (2013)
Differentiating Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis from Other Forms of Hemophagocytic Lymphohistiocytosis
Kai Lehmberg et al.
JOURNAL OF PEDIATRICS (2013)
Reaching the Threshold: A Multilayer Pathogenesis of Macrophage Activation Syndrome
Raffaele Strippoli et al.
JOURNAL OF RHEUMATOLOGY (2013)
Familial and Acquired Hemophagocytic Lymphohistiocytosis
G. E. Janka
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Amplification of the response to toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: Implication for the pathogenesis of macrophage activation syndrome
Raffaele Strippoli et al.
ARTHRITIS AND RHEUMATISM (2012)
Macrophage Activation Syndrome in Children With Systemic Lupus Erythematosus and Children With Juvenile Idiopathic Arthritis
Tellen D. Bennett et al.
ARTHRITIS AND RHEUMATISM (2012)
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases
Cheng-I Lin et al.
CLINICAL RHEUMATOLOGY (2012)
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
A. Ravelli et al.
GENES AND IMMUNITY (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India
Surjit Singh et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein
Laura Chiossone et al.
FRONTIERS IN IMMUNOLOGY (2012)
Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice
Edward M. Behrens et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
Paivi M. Miettunen et al.
RHEUMATOLOGY (2011)
Macrophage activation syndrome: advances towards understanding pathogenesis
Alexei A. Grom et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus - case report and literature review
G. Carvalheiras et al.
LUPUS (2010)
Macrophage Activation Syndrome in Juvenile Systemic Lupus Erythematosus A Multinational Multicenter Study of Thirty-Eight Patients
Alessandro Parodi et al.
ARTHRITIS AND RHEUMATISM (2009)
Anakinra for Systemic Juvenile Arthritis The Rocky Mountain Experience
Andrew Zeft et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis
Ahha Gupta et al.
PEDIATRIC BLOOD & CANCER (2008)
Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis
Hua-Song Zeng et al.
WORLD JOURNAL OF PEDIATRICS (2008)
Infections associated with haemophagocytic syndrome
Nadine G. Rouphael et al.
LANCET INFECTIOUS DISEASES (2007)
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis
Jack Bleesing et al.
ARTHRITIS AND RHEUMATISM (2007)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Macrophage activation syndrome in juvenile idiopathic arthritis
Elisabetta Cortis et al.
ACTA PAEDIATRICA (2006)
Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients - A postmortem clinicopathologic analysis
R Strauss et al.
CRITICAL CARE MEDICINE (2004)
Reactive hemophagocytic syndrome in adult systemic disease: Report of twenty-six cases and literature review
R Dhote et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Reactive haemophagocytic syndrome in children with inflammatory disorders.: A retrospective study of 24 patients
JL Stéphan et al.
RHEUMATOLOGY (2001)
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
S Sawhney et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Share Paper
